X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1365) 1365
Publication (63) 63
Book Review (7) 7
Book Chapter (6) 6
Magazine Article (2) 2
Web Resource (2) 2
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1020) 1020
female (994) 994
middle aged (563) 563
aged (507) 507
oncology (460) 460
obstetrics & gynecology (432) 432
uterus (408) 408
index medicus (374) 374
mixed tumor, mullerian - pathology (357) 357
uterine neoplasms - pathology (355) 355
carcinosarcoma (347) 347
pathology (333) 333
adult (310) 310
mixed mullerian tumors (300) 300
immunohistochemistry (256) 256
aged, 80 and over (225) 225
cancer (216) 216
carcinosarcoma - pathology (213) 213
prognosis (189) 189
neoplasm staging (183) 183
chemotherapy (180) 180
ovarian neoplasms - pathology (162) 162
carcinoma (160) 160
tumors (156) 156
retrospective studies (152) 152
malignant mixed mullerian tumor (148) 148
gynecologic-oncology-group (140) 140
sarcoma (127) 127
mixed tumor, mullerian - surgery (125) 125
ovary (119) 119
uterine neoplasms - surgery (115) 115
female genital-tract (110) 110
surgery (110) 110
endometrial cancer (105) 105
mixed mullerian tumor (101) 101
treatment outcome (100) 100
prognostic-factors (98) 98
diagnosis, differential (97) 97
survival (96) 96
hysterectomy (95) 95
combined modality therapy (93) 93
endometrial neoplasms - pathology (92) 92
male (91) 91
mixed tumor, mullerian - diagnosis (90) 90
uterine carcinosarcoma (88) 88
uterine neoplasms - therapy (85) 85
carcinosarcoma - surgery (84) 84
survival rate (83) 83
antineoplastic combined chemotherapy protocols - therapeutic use (82) 82
therapy (82) 82
expression (80) 80
chemotherapy, adjuvant (79) 79
mesodermal tumors (78) 78
malignant mixed müllerian tumor (74) 74
cisplatin (73) 73
mixed tumor, mullerian - drug therapy (72) 72
diagnosis (70) 70
stage-i (70) 70
ifosfamide (69) 69
sarcoma - pathology (69) 69
adenosarcoma (68) 68
uterine neoplasms - mortality (68) 68
uterine sarcoma (68) 68
analysis (67) 67
ovarian cancer (67) 67
prognostic factors (67) 67
uterine neoplasms - metabolism (66) 66
mixed tumor, mullerian - therapy (65) 65
disease-free survival (63) 63
ovarian neoplasms - surgery (63) 63
sarcomas (62) 62
adenocarcinoma (61) 61
radiotherapy, adjuvant (61) 61
radiotherapy (60) 60
uterine neoplasms - diagnosis (60) 60
uterine neoplasms - drug therapy (60) 60
carcinosarcoma - therapy (59) 59
endometrial stromal sarcoma (59) 59
mesodermal tumor (59) 59
mixed tumor, mullerian - metabolism (59) 59
carcinosarcoma - drug therapy (58) 58
differentiation (58) 58
hematology, oncology and palliative medicine (58) 58
obstetrics and gynecology (58) 58
care and treatment (57) 57
survival analysis (57) 57
adolescent (56) 56
mutation (56) 56
carcinosarcoma - metabolism (55) 55
carcinosarcoma - mortality (55) 55
biomarkers, tumor - analysis (54) 54
endometrium (54) 54
leiomyosarcoma (54) 54
mullerian tumors (53) 53
adenocarcinoma - pathology (52) 52
adenosarcoma - pathology (51) 51
endometrial carcinoma (51) 51
ovarian neoplasms - drug therapy (51) 51
follow-up studies (50) 50
phase-iii trial (50) 50
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1212) 1212
Korean (38) 38
French (34) 34
German (30) 30
Japanese (18) 18
Spanish (18) 18
Italian (6) 6
Turkish (6) 6
Russian (5) 5
Chinese (4) 4
Bulgarian (3) 3
Portuguese (3) 3
Czech (2) 2
Polish (2) 2
Bosnian (1) 1
Hungarian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Medicine, ISSN 0025-7974, 10/2018, Volume 97, Issue 42, p. e12903
Rationale: Malignant mixed Mullerian tumor (MMMT) of extragenital organs is rare, especially in male. To our knowledge, this is the first reported case of... 
carcinosarcoma | ADENOSARCOMA | MEDICINE, GENERAL & INTERNAL | mesodermal | MESODERMAL TUMOR | malignant mixed Mullerian tumor | mediastinum | Neoplasm Recurrence, Local - pathology | Mediastinal Neoplasms - pathology | Humans | Middle Aged | Fatal Outcome | Male | Mediastinum - pathology | Mixed Tumor, Mullerian - pathology
Journal Article
Journal of Computer Assisted Tomography, ISSN 0363-8715, 03/2015, Volume 39, Issue 2, pp. 276 - 280
We illustrate the magnetic resonance imaging features of 3 cases of rare ovarian Mullerian mixed epithelial borderline tumor (MEBT) and identify important... 
endometriosis | ovary | Mullerian mixed epithelial borderline tumor | MRI | borderline tumor | MALIGNANCY | CLINICOPATHOLOGIC ANALYSIS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PAPILLARY CYSTADENOMAS | Magnetic Resonance Imaging | Humans | Middle Aged | Ovarian Neoplasms - pathology | Female | Aged | Mixed Tumor, Mullerian - pathology
Journal Article
Human Pathology, ISSN 0046-8177, 07/2016, Volume 53, pp. 159 - 167
The stage I uterine malignant mixed mullerian tumor (MMMT) shows different potential for progression. We reason that MMMTs with high-grade carcinomatous... 
Malignant mixed mullerian tumor (MMMT) | Tissue microarrays (TMA) | AJCC stage | Epidermal growth factor receptor (EGFR) | Serous carcinoma | Integrin-α5 | Heparin-binding epidermal growth factor-like growth factor (HB-EGF) | PROGNOSTIC-FACTORS | INTEGRIN | PATTERNS | ALPHA | CELL-ADHESION | OVARIAN-CANCER | PATHOLOGY | Integrin-alpha 5 | INVASION | EXPRESSION | CLINICAL-SIGNIFICANCE | Immunohistochemistry | Neoplasms, Cystic, Mucinous, and Serous - surgery | Tissue Array Analysis | Uterine Neoplasms - pathology | Humans | Middle Aged | Mixed Tumor, Malignant - surgery | Mixed Tumor, Malignant - secondary | Neoplasms, Cystic, Mucinous, and Serous - secondary | Mixed Tumor, Malignant - chemistry | Female | Integrin alpha5 - analysis | Retrospective Studies | Mixed Tumor, Mullerian - chemistry | Neoplasms, Cystic, Mucinous, and Serous - chemistry | Uterine Neoplasms - chemistry | Mixed Tumor, Mullerian - surgery | Biomarkers, Tumor - analysis | Heparin-binding EGF-like Growth Factor - analysis | Neoplasm Invasiveness | Neoplasm Recurrence, Local | Treatment Outcome | Receptor, Epidermal Growth Factor - analysis | Mixed Tumor, Mullerian - secondary | Uterine Neoplasms - surgery | Aged | Neoplasm Staging | Cell Movement | Anticoagulants (Medicine) | Epidermal growth factor | Metastasis | Analysis | Integrins | Cellular biology | Medical prognosis | Mortality | Biomarkers | Histology | Cell adhesion & migration | Tumors | Ovarian cancer
Journal Article
International Journal of Gynecological Cancer, ISSN 1048-891X, 11/2002, Volume 12, Issue 6, pp. 687 - 690
. McCluggage WG. Uterine carcinosarcomas (malignant mixed mullerian tumors) are metaplastic carcinomas. Uterine carcinosarcomas (malignant mixed Mullerian... 
carcinosarcoma | uterus | Uterus | Carcinosarcoma | PROGNOSTIC FACTORS | GYNECOLOGIC-ONCOLOGY-GROUP | ENDOMETRIUM | ANGIOGENESIS | FEMALE GENITAL-TRACT | OBSTETRICS & GYNECOLOGY | ELEMENTS | ONCOLOGY | SARCOMA | TERM TAMOXIFEN TREATMENT | ASSOCIATION | Female | Uterine Neoplasms - pathology | Humans | Mixed Tumor, Mullerian - pathology
Journal Article
Medicine, ISSN 0025-7974, 07/2018, Volume 97, Issue 28, p. e11311
Rationale: Primary malignant mixed mullerian tumors of the fallopian tube is very rare and has only 1 case in the current literature with cervix metastasis.... 
magnetic resonance imaging (MRI) | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | CARBOPLATIN | cervix metastasis | fallopian tube | PATIENT | CARCINOMA | malignant mixed Mullerian tumors (MMMTs) | PACLITAXEL
Journal Article
Journal Article
Revue Medicale de Bruxelles, ISSN 0035-3639, 05/2018, Volume 39, Issue 3, pp. 146 - 149
Journal Article
Journal Article
STEM CELLS, ISSN 1066-5099, 10/2011, Volume 29, Issue 10, pp. 1485 - 1495
Cancer stem cells (CSCs) that display tumor‐initiating properties have recently been identified. CD133, a surface glycoprotein linked to organ‐specific stem... 
Cancer stem cell | Uterine carcinosarcoma | Müllerian duct | Malignant mixed Müllerian tumor | CD133 | PROGNOSIS | UTERUS | STAGE | SELF-RENEWAL | PLURIPOTENCY | Malignant mixed Mullerian tumor | CELL & TISSUE ENGINEERING | CELL BIOLOGY | SIDE-POPULATION | ONCOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | MYC | Mullerian duct | STEM/PROGENITOR CELLS | NANOG | HEMATOLOGY | EXPRESSION | Immunohistochemistry | Neoplastic Stem Cells - cytology | Wnt4 Protein - metabolism | PAX2 Transcription Factor - metabolism | Paclitaxel - pharmacology | Neoplastic Stem Cells - drug effects | Uterine Neoplasms - pathology | Vimentin - metabolism | Homeodomain Proteins - metabolism | Humans | Gene Expression Regulation, Neoplastic | Glycoproteins - metabolism | Drug Resistance, Neoplasm | Antigens, CD - metabolism | Epithelial Cell Adhesion Molecule | SOXB1 Transcription Factors - metabolism | Estrogen Receptor beta - metabolism | Mesenchymal Stromal Cells - cytology | Flow Cytometry | Peptides - metabolism | Antigens, Neoplasm - metabolism | Neoplastic Stem Cells - pathology | Female | Cell Differentiation | Mixed Tumor, Mullerian - metabolism | Carcinosarcoma - pathology | Uterine Neoplasms - genetics | Uterine Neoplasms - metabolism | Carcinosarcoma - metabolism | Nanog Homeobox Protein | Mesenchymal Stromal Cells - metabolism | Cell Separation - methods | Cisplatin - pharmacology | AC133 Antigen | Cell Adhesion Molecules - metabolism | Cell Transformation, Neoplastic - metabolism | Mixed Tumor, Mullerian - pathology | Animals | Mice, Nude | Octamer Transcription Factor-3 - metabolism | Cell Line, Tumor | Carcinosarcoma - genetics | Mice | Mice, Inbred BALB C | Cell Transformation, Neoplastic - pathology
Journal Article
Archives of Gynecology and Obstetrics, ISSN 0932-0067, 8/2016, Volume 294, Issue 2, pp. 343 - 351
There is low evidence regarding the optimal treatment in patients with uterine sarcomas and malignant mixed Mullerian tumors (MMMTs). This study provides an... 
Human Genetics | Medicine & Public Health | Undifferentiated endometrial sarcoma | Gynecology | Outcome | Obstetrics/Perinatology | Leiomyosarcoma | Uterine sarcoma | Malignant mixed Mullerian tumor | Endometrial stromal sarcoma | Endocrinology | ADJUVANT CHEMOTHERAPY | MANAGEMENT | UTERUS | RANDOMIZED CLINICAL-TRIAL | CARCINOSARCOMAS | STAGE-I | FEATURES | OBSTETRICS & GYNECOLOGY | LYMPHADENECTOMY | RADIOTHERAPY | Multivariate Analysis | Prognosis | Endometrial Neoplasms - mortality | Uterine Neoplasms - pathology | Humans | Middle Aged | Sarcoma, Endometrial Stromal - therapy | Endometrial Stromal Tumors - mortality | Sarcoma, Endometrial Stromal - mortality | Sarcoma, Endometrial Stromal - pathology | Mixed Tumor, Mullerian - therapy | Uterine Neoplasms - mortality | Adult | Female | Mixed Tumor, Mullerian - mortality | Leiomyosarcoma - pathology | Kaplan-Meier Estimate | Proportional Hazards Models | Survival Rate | Combined Modality Therapy | Endometrial Stromal Tumors - therapy | Sarcoma - pathology | Mixed Tumor, Mullerian - pathology | Leiomyosarcoma - therapy | Disease-Free Survival | Uterine Neoplasms - surgery | Endometrial Neoplasms - therapy | Leiomyosarcoma - mortality | Endometrial Neoplasms - pathology | Aged | Endometrial Stromal Tumors - pathology | Endometrial cancer | Sarcoma | Health aspects | Analysis | Multivariate analysis | Uterine cancer | Medical prognosis
Journal Article
CASE REPORT - MALIGNANT MIXED MULLERIAN TUMOUR, HETEROLOGOUS IN A 66-YEAR-OLD MALAY LADY - A CASE REPORT, 07/2003
A 66-year-old Malay woman, known hypertensive, presented with post menopausal bleeding associated with clot for three months. She was postmenopausal for last... 
Health | Malignant Mixed Mullerian Tumour, Heterologous. mj03030
Journal